Skip to main content

Table 2 Characteristics of bacterial isolates

From: Increased rate of enteric bacteria as cause of periprosthetic joint infections in patients with liver cirrhosis

Bacterial isolates

Total (n = 60)

RI-group (n = 13)

NRI-group (n = 18)

 

n

%

n

%

n

%

Staphylococcus aureus

5

8.3

1 (0)

7.7

4 (0)

22.2

Staphylococcus epidermidis

12

20

5 (5)

38.5

7 (1)

38.9

Staphylococcus haemolyticus

3

5

2 (2)

15.4

1 (0)

5.6

Staphylococcus hominis

3

5

2 (0)

15.4

1 (0)

5.6

Staphylococcus lugdunensis

1

1.7

1 (0)

7.7

/

/

Staphylococcus intermedius

1

1.7

/

/

1 (0)

5.6

Streptococcus mitis/oralis

1

1.7

/

/

/

/

Streptococcus salivarius

1

1.7

/

/

/

/

Cutibacterium acnes

2

3.3

1 (1)

7.7

1 (0)

5.6

Enterococcus faecalis

7

11.7

1 (1)

7.7

1 (1)

5.6

Enterococcus faecium

6

10

/

/

1 (1)

5.6

Enterococcus hirae

1

1.7

/

/

1 (1)

5.6

Clostridioides difficile

1

1.7

/

/

/

/

Enterobacter cloacae

4

6.7

/

/

/

/

Pseudomonas aeruginosa

4

6.7

/

/

/

/

Escherichia coli

2

3.3

/

/

/

/

Klebsiella oxytoca

1

1.7

/

/

/

/

Proteus mirabilis

2

3.3

/

/

/

/

Proteus vulgaris

1

1.7

/

/

/

/

Serratia marcescens

2

3.3

/

/

/

/

  1. (n) amount of isolates with resistance to Rifampicin
  2. Bacterial isolates in the NRI-/RI-group (Rifaximin intake or no Rifaximin intake) and susceptibility to Rifampicin in both groups (in brackets)